BRAINSTORM CELL THERAPEUTICS INC. Interest Income (Expense), Nonoperating, Net
Financial Statements › Income Statement
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-14
- BRAINSTORM CELL THERAPEUTICS INC. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was -$242.00K.
- BRAINSTORM CELL THERAPEUTICS INC. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was -$81.00K, a 276.09% decline year-over-year.
- BRAINSTORM CELL THERAPEUTICS INC. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was -$190.00K.
- BRAINSTORM CELL THERAPEUTICS INC. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was -$59.00K.
- BRAINSTORM CELL THERAPEUTICS INC. interest income (expense), nonoperating, net for fiscal 2025 was -$533.00K.
- BRAINSTORM CELL THERAPEUTICS INC. interest income (expense), nonoperating, net for fiscal 2024 was -$77.00K.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$242.00K 10-Q · filed 2026-08-14 | -$323.00K 10-Q · filed 2026-08-14 | -$513.00K derived: sum of 3 quarters · filed 2026-08-14 | -$572.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$81.00K 10-Q · filed 2026-05-15 | -$271.00K derived: sum of 2 quarters · filed 2026-05-15 | -$330.00K derived: sum of 3 quarters · filed 2026-05-15 | -$660.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$249.00K derived: sum of 2 quarters · filed 2026-03-31 | -$579.00K derived: sum of 3 quarters · filed 2026-08-14 | -$533.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$59.00K 10-Q · filed 2025-11-14 | -$389.00K derived: sum of 2 quarters · filed 2026-08-14 | -$343.00K 10-Q · filed 2025-11-14 | -$409.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$330.00K 10-Q · filed 2026-08-14 | -$284.00K 10-Q · filed 2026-08-14 | -$350.00K derived: sum of 3 quarters · filed 2026-08-14 | -$404.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $46.00K 10-Q · filed 2026-05-15 | -$20.00K derived: sum of 2 quarters · filed 2026-05-15 | -$74.00K derived: sum of 3 quarters · filed 2026-05-15 | -$44.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$120.00K derived: sum of 2 quarters · filed 2026-03-31 | -$90.00K derived: sum of 3 quarters · filed 2026-03-31 | -$77.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$54.00K 10-Q · filed 2025-11-14 | -$24.00K derived: sum of 2 quarters · filed 2025-11-14 | -$11.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $30.00K 10-Q · filed 2025-08-14 | $43.00K 10-Q · filed 2025-08-14 |